US provider directory / Profile

Mochi Health

Subscription telehealth with physician and dietitian access plus separate compounded or brand-name medication paths.

Leer el resumen en español ↓
  • Insurance help
  • Brand route
  • Coaching
  • Switching support
Research checkedSep 13, 2026
2 cited sourcesUS profile
Editorial note

This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.

At a glance

Price view$79/month membership; medication separateMochi displayed a $79 standard monthly membership after promotion. Medication prices and availability vary by state and route.
Payment routesCash pay · Insurance helpBrand access may involve insurance; confirm administrative fees and the expected pharmacy copay separately.
Medicines and brand contextSemaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes)Only if prescribed, appropriate, and available for the relevant indication.
GeographyUS multi-state; confirm at intakeConfirm during intake.
Service modelMembership plus medicationTelehealth program
Format and supportInjection · Oral medicineCoaching · Clinician support · Switching pathway · Home delivery
Evidence reviewed2 cited sources

Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.

Still to confirm4 open checks

An open check means the public sources were not specific enough—not that the service failed the check.

Resumen en español

Mochi Health para usuarios hispanohablantes

Idioma de la consulta no confirmado

Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.

Mercado revisadoEstados Unidos
Forma de pagoPago directo · Seguro médico
Ruta publicadaMedicamento de marca · Preparación compuesta
Idioma de la atención

No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.

Antes de pagar, confirma:
  • si la cita concreta será en español;
  • el coste mensual ordinario y qué incluye;
  • la licencia estatal del profesional;
  • el medicamento, la farmacia y el coste por separado.

Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.

Comparar proveedores para hispanohablantes en EE. UU. →

How the program is structured

A $79 monthly clinical membership with physician, dietitian, coaching, and messaging access. Medication and diagnostics are separate, with an unusually broad current cash menu spanning compounded and FDA-approved brand options.

GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.

Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.

Research confidence High Confidence reflects public-source specificity, not clinical quality.

Service configuration

These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.

Provider type
Telehealth program
Medicine context
Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes)
Formats reviewed
Injection · Oral medicine
Funding routes
Private pay · Insurance support
Service features
Coaching · Clinician support · Switching pathway · Home delivery
Access check
Confirm current state access
Evidence status
Primary sources reviewed
Research depth
2 cited sources · 4 medicine rows · 4 open checks

Recurring cost breakdown

  • $79 standard monthly membership; a $39 first-month promotion was displayed at review.
  • Medication and diagnostics are not included in the membership.
  • Published starting medication prices vary by product and state; a low medication headline must be added to the membership to compare the recurring total.
  • Shipping and higher-dose pricing should be confirmed in the patient-specific offer.
Build the actual monthly total from
  • Medicine + dose
  • Membership or consultation
  • Delivery + supplies
  • Labs + follow-up
  • Renewal after offers

Medication and formulation matrix

MedicationFormRegulatory / program pathPublished price view
Compounded semaglutideInjection or pill as offeredNot FDA-approvedFrom $60 injection / $62 pill + $79 membership
Compounded tirzepatideWeekly injectionNot FDA-approvedFrom $90 + $79 membership
Wegovy / OzempicBrand pill or pen as offeredFDA-approved brands; indication differsFrom $149–$199 + membership at review
Zepbound / MounjaroWeekly injectionFDA-approved brands; indication differsFrom $299 / $499 + membership at review

Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.

State-by-state availability

  • Mochi advertises broad US access, but pricing and medication availability vary by state.
  • Confirm both clinician and pharmacy eligibility during intake.

Clinician access and follow-up cadence

  • Board-certified provider access and care-team messaging are included.
  • Dietitian and coaching access are advertised, including 24/7 care-team availability.
  • Confirm how often a live visit is required for refills in the patient’s state.

Pharmacy and fulfillment

  • Treatment is delivered through pharmacy partners.
  • The reviewed marketing page does not assign a named pharmacy to each state and formulation; the prescription label should identify the actual dispenser.

Insurance and prior authorization

  • Cash medication and brand/insurance paths are offered.
  • Membership is separate from medication coverage; prior authorization does not guarantee approval or a particular copay.

Cancellation, refund, and commitment

  • The membership renews monthly unless canceled under the current account terms.
  • The public pricing page did not fully state refund treatment for medication already sent to a pharmacy; confirm the cutoff before the next order.

Labs, monitoring, and dose management

  • Diagnostics are explicitly separate from the $79 membership.
  • Ask which baseline and repeat labs apply to the prescribed medication and who pays the lab.

Maintenance and switching

  • Mochi markets ongoing clinical support that can fit maintenance, but continued medication and dose remain clinician decisions.
  • For a transfer, confirm document requirements and the next refill date before paying both programs.

Program snapshot

Care model

Membership plus medication

Profiled support: Ongoing clinician access, Coaching or behavior support.

Payment and coverage

Cash pay · Insurance help

Brand access may involve insurance; confirm administrative fees and the expected pharmacy copay separately.

Pharmacy and fulfillment

Verify before purchase

Compounded dispensing may vary by state. Request the pharmacy name, formulation, storage, and shipment details.

What the advertised program may include

  • Physician visits
  • Dietitian access
  • Care-team messaging
  • Medication access when prescribed

Useful comparison signals

Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.

  • Starting care and comparing first-provider requirements
  • Switching providers or continuing an established treatment
  • Comparing lower-cost access routes and recurring totals
  • Ongoing clinician access
  • Coaching or behavior support

Open evidence gaps

These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.

  • Named pharmacy by state/product
  • Universal live-visit cadence
  • Diagnostic price schedule
  • Medication-order refund cutoff

Questions to ask before paying

  1. What is the ordinary recurring total after any introductory period?
  2. Does that total include clinician care, medication, supplies, labs, and shipping?
  3. Which clinician group and dispensing pharmacy will be responsible for my care?
  4. What happens to billing if I am not prescribed the advertised treatment?
  5. What records and timing do you require if I am switching from another provider?

Source ledger

Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.